Yesterday, 19 August 2026, Sandvik Coromant hosted the ESS Innovation Day 2026, in Sandviken, Sweden. The event is the fifth edition to bring together research d...

Study in mAbs describes the first reported demonstration of a reversible trans-activation logic gate for tumour-conditional cytokine delivery FJBio engineere...

Investment in new premises in London reflects significant milestone in Company's growth, following $20 million Series B financing Supports rapid scale-up and...

Final results from the CNS-102 study, published in Scientific Reports, show that the at-home NeuLogiq® Platform can be deployed successfully in patients with si...

Keelira offers an integrated, sponsor-side approach for biotech and pharma companies, including those based in the US and China, seeking to extend oncology prog...

Rapid access to custom liquid and powder media helps scientists move from formulation design to process decisions faster, while supporting a clearer path to fut...

Non-invasive cell-free DNA liquid biopsy platform for multi-organ monitoring of drug-safety across preclinical and clinical settings Early access programme n...

·        CHO.SET® 2.0 library of synthetic promoters provide tuneable expression of transgenes whilst maximising CHO...

The University Hospital Cologne (Universitätsklinikum Köln, UHC) has chosen the Celonic Group as its CDMO partner for advanced process development and GMP manufa...

Grant funding delivered in partnership with the NC3Rs, in support of UK Government roadmap to reduce animal testing by 2030 Project to develop standardized w...